Company page

Mineralys Therapeutics, Inc.

Mineralys Therapeutics, Inc. is a public company traded under the ticker MLYS in the American market. The company has a market capitalization of approximately $1.95 billion. Mineralys focuses on developing innovative therapies, although specific product details and financial metrics are not provided.